BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Policy

  Depomed, Inc. Summary Judgment Motion Granted In Suit Against FDA Seeking Orphan Drug Exclusivity For Gralise® (Gabapentin)

  September 5, 2014

   · 

  2 min read
• BioMidwest

  TOLMAR Pharmaceuticals Continues Commitment To Prostate Cancer Community, Supports ZERO Campaign

  September 5, 2014

   · 

  3 min read
• Biotech Bay

  Depomed, Inc. Announces Pricing Of Upsized $300 Million Convertible Senior Notes Due 2021

  September 5, 2014

   · 

  5 min read
• Business

  Misonix Incorporated To Report Fourth Quarter And Fiscal Year 2014 Financial Results On Wednesday, September 10, 2014

  September 5, 2014

   · 

  2 min read
• Business

  Tamarisk Technologies Group Announces New Addition To Science Team

  September 5, 2014

   · 

  3 min read
• Lone Star Bio

  VC Firm Targeted Technology Secures $40 Million+ Geared Towards Early-Stage Biotechs

  September 5, 2014

   · 

  1 min read
• Business

  Pfizer Strikes Pact To Market Novartis AG’s Respiratory Inhalers In The UK

  September 5, 2014

   · 

  1 min read
• Business

  Intrexon Announces The Appointment Of Keith Canada As Vice President, UltraVector® Division

  September 5, 2014

   · 

  4 min read
• Business

  Gilead Close To Inking Deal That Would Bring Low-Cost Versions Of $84,000 Solvadi Drug To Poor Countries

  September 5, 2014

   · 

  1 min read